Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1934
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain ; volume:36 ; number:5 ; day:23 ; month:4 ; year:2022 ; pages:517-527 ; date:5.2022
CNS drugs ; 36, Heft 5 (23.4.2022), 517-527, 5.2022
- Urheber
-
Gutiérrez‐Rojas, Luis
Sánchez-Alonso, Sergio
García Dorado, Marta
López Rengel, Paola M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40263-022-00917-1
- URN
-
urn:nbn:de:101:1-2022071706324862172056
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gutiérrez‐Rojas, Luis
- Sánchez-Alonso, Sergio
- García Dorado, Marta
- López Rengel, Paola M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study